
Research Report Analysis: Breakthrough in the Wafer-Scale Chip Sector—Cerebras’ IPO Debut Exceeds Expectations
TechFlow Selected TechFlow Selected

Research Report Analysis: Breakthrough in the Wafer-Scale Chip Sector—Cerebras’ IPO Debut Exceeds Expectations
Market concerns regarding the company’s technological scalability have been alleviated.
Author: Rita
TideResearch Executive Summary
Morgan Stanley released its first follow-up report on Cerebras Systems following the company’s IPO on June 24, raising its price target from $250 to $273 and maintaining an Overweight rating. The chipmaker holds a unique position in the fast inference space, with both revenue and gross margin in its latest earnings report exceeding expectations. Analysts believe that the 750 MW capacity agreement and its in-house cloud services initiative will drive high growth over the next two years. Crucially, market concerns regarding the scalability of the company’s technology have now been resolved.
Q1 Results Exceed Expectations
Cerebras delivered solid results for the March 2026 quarter. Revenue reached $193.4 million, up 13% quarter-on-quarter and above consensus. Non-GAAP gross margin stood at 46.5%—not exceptionally high, but commendable given the company’s current reliance on rented servers to deliver services.
Morgan Stanley notes that management’s guidance is relatively conservative—leaving room for potential upward revisions. FY2026 revenue guidance stands at $864 million, significantly higher than the prior-year period. FY2027 revenue is expected to reach $2.714 billion—nearly triple that amount.

Gross margin is projected to rise rapidly—from 39.4% in FY2026 to 51.1% in FY2027 and further to 57.9% in FY2028. This improvement hinges on Cerebras’ transition from renting third-party hardware to building its own cloud infrastructure. Rented-server gross margin sits at just 37%, while the long-term gross margin target for its in-house cloud services is 57.9%—a fundamental shift in profitability.
750 MW Agreement Anchors Growth
Cerebras has secured formal agreements for 750 MW of capacity. This 750 MW commitment reflects clear customer demand and effectively locks in a revenue floor for the next two to three years. While many chipmakers still compete for orders, Cerebras has already secured long-term capacity commitments. The agreement spans multiple customers, and its collaboration with Amazon has progressed from a letter of intent to a formal contract. Although analysts remain conservative in estimating Amazon’s contribution, this leaves ample room for upside in future growth.
Market skepticism around Cerebras’ wafer-scale processors—particularly whether its architecture can truly support large-scale models—has now been decisively addressed. The company successfully validated real-world performance on trillion-parameter models (e.g., Kimi K2.6), proving the scalability of its architecture. With technical risk removed, investor focus naturally shifts to commercial execution—and the 750 MW capacity agreement serves as strong evidence of customer confidence in the technology.
Inference Chips Emerge as the New Battleground
Why fast inference—not training? Because inference is becoming the fastest-growing segment of AI infrastructure spending. Training represents a one-time investment; inference is ongoing and repeated. As large-model applications proliferate, inference costs will increasingly dominate overall AI chip expenditure.
Cerebras’ leadership in fast inference grants it a distinctive market position. Most competitors concentrate on training chips, whereas Cerebras has pursued a differentiated path focused on inference—a specialization that has become a competitive advantage.
Three Scenarios and Price Target
Morgan Stanley outlines three scenarios. Under the base case, adjusted revenue reaches $6 billion in 2028, implying a target price of $273. This is the scenario analysts deem most probable, predicated on timely deployment of the full 750 MW capacity. In the bull case, capacity deployment exceeds expectations—reaching over 1 GW—potentially pushing 2028 revenue beyond $10 billion and lifting the target price to $400. In the bear case, capacity deployment is delayed, limiting 2028 revenue to $2.7 billion and reducing the target price to $90.
As of June 23, 2026, Cerebras’ share price closed at $226.72—representing ~20% upside to the $273 target price. Even relative to the market consensus target of $250, there remains ~10% upside. Morgan Stanley’s upward revision reflects growing confidence in the company’s execution certainty.

Risks and Opportunities
The primary risk lies in capacity deployment timing—if construction of large-scale data centers faces delays, Cerebras’ revenue growth will be correspondingly impacted. Customer concentration presents another risk: any material change in demand from key clients could significantly affect the company. Conversely, successful deployment opens the door to acquiring new customers. The inference chip market continues to expand rapidly, and Cerebras’ differentiated offering positions it well to attract additional clients.
Cerebras has evolved—from a controversial startup into a company backed by firm, contracted demand—thanks to its first-quarter results and technical validation. This transformation is pivotal. Morgan Stanley’s upward price target revision reflects recognition of this newfound certainty. While the wafer-scale chip赛道 remains volatile, Cerebras has firmly established leadership in fast inference. Over the next two years, whether the company delivers on its projected revenue and margin improvements will determine investor returns.

Disclaimer
This article is TideResearch’s summary and interpretation of a third-party brokerage research report. Ratings, price targets, earnings forecasts, and related judgments cited herein reflect the views of Morgan Stanley analysts only and represent the stance of their respective institution—not TideResearch’s views—and do not constitute investment advice.
Please note three points when reading: First, price targets reflect analysts’ expectations for the next ~12 months—not guarantees—and are subject to frequent revision based on financial performance and market conditions. Second, sell-side reports are inherently bullish, and some covered companies may have investment banking relationships with the issuing brokerages. Third, the value of a research report lies in its core logic and underlying assumptions—not in any single price target. Focus on the logic—not just the number.
Markets carry risks; decisions must be made independently. This article should not serve as the basis for buying or selling any securities.
Data source: Morgan Stanley Research Report (Joseph Moore, June 24, 2026) · Public market data
TideResearch · 2026 June
Join TechFlow official community to stay tuned
Telegram:https://t.me/TechFlowDaily
X (Twitter):https://x.com/TechFlowPost
X (Twitter) EN:https://x.com/BlockFlow_News












